Pembrolizumab (NSCLC): Powder for injection 50 mg, solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 13 July 2018 Public Summary Document (PSD) March 2018 PBAC Meeting - (PDF 135 KB) Public Summary Document (PSD) March 2018 PBAC Meeting - (Word 42 KB)